Drugs / cassia seed tablet
cassia seed tablet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04252131 | May 2018 → Oct 2019 | schizophrenia | Calo Psychiatric Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cassia seed tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04252131 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “traditional Chinese herbs” NCT04252131 ↗ |
| Route | Oral | “oral administration of Cassia seed (3.0g), once/day for 12 weeks” NCT04252131 ↗ |